Skip to main content

Metin Colpan, Peer Schatz, Christian Henry, Cedric Loiret-Bernal, Michael Kranda, Paul Allen, Robert Rosenthal


Metin Colpan, CEO of Venlo, Netherlands-based Qiagen will transition to senior technology advisor and will join the supervisory board beginning on Jan. 1, the company said this week. Peer Schatz, who has served as chief financial officer of Qiagen for the past 11 years, has been named CEO.

Christian Henry the former vice president, finance, and corporate controller of Affymetrix, has been appointed chief financial officer of

Cedric Loiret-Bernal, the co-founder and former CEO of Geneva Proteomics, has been named president and CEO of NanoInk, the Chicago firm said last week. Loiret-Bernal co-founded GeneProt in 2000, but left last April, and joined CDP Capital Technology Ventures, a Canadian institutional investment firm, where he served as a venture advisor for US life sciences investments.

Before founding GeneProt, Loiret-Bernal was a senior investment analyst and partner at Brinson Partners, which is now part of UBS Global Asset Management, and has also held positions in strategic planning at Abbott Laboratories and in marketing at Haemonetics and Porges-Synthelabo.

Michael Kranda has joined Vulcan, the investment and project management company for the assets of Microsoft co-founder Paul Allen, to direct life sciences investment, the firm said last week. Kranda is the former CEO of Oxford Glycosciences, which was acquired by UK biotech firm Celltech in June. Prior to that, he was president, COO and director at Immunex.

Robert Rosenthal has been appointed president and chief executive officer of TekCel, the Hopkinton, Mass., liquid handling and sample management tools company said. Rosenthal was formerly president of PerkinElmer’s instrument’s division. Prior to that, Rosenthal was president and CEO of Thermo Optek, an instrument company that went public in 1996. Before that, he was president of Nicolet Instrument, a subsidiary of Thermo Instruments. Rosenthal replaces Herbert Hooper, who is an operating partner at Ampersand Ventures, the lead investor in the company, and was serving as interim CEO of TekCel since August 2003.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.